Your browser doesn't support javascript.
loading
Short-term prognosis of low-risk prostate cancer patients is favorable despite the presence of pathological prognostic factors: a retrospective study.
Semba, Remi; Uchida, Katsunori; Hirokawa, Yoshihumi; Shiraishi, Taizo; Onishi, Takehisa; Sasaki, Takeshi; Inoue, Takahiro; Watanabe, Masatoshi.
Afiliação
  • Semba R; Department of Oncologic Pathology, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu, Mie, 514-8507, Japan.
  • Uchida K; Department of Pathology, Kuwana City Medical Center, Kuwana, Mie, Japan.
  • Hirokawa Y; Department of Oncologic Pathology, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu, Mie, 514-8507, Japan. kubjh@med.mie-u.ac.jp.
  • Shiraishi T; Department of Oncologic Pathology, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu, Mie, 514-8507, Japan.
  • Onishi T; Department of Pathology, Kuwana City Medical Center, Kuwana, Mie, Japan.
  • Sasaki T; Department of Urology, Japanese Red Cross Ise Hospital, Ise, Mie, Japan.
  • Inoue T; Department of Nephro-Urologic Surgery and Andrology, Mie University Hospital, Tsu, Mie, Japan.
  • Watanabe M; Department of Nephro-Urologic Surgery and Andrology, Mie University Hospital, Tsu, Mie, Japan.
BMC Urol ; 23(1): 174, 2023 Oct 31.
Article em En | MEDLINE | ID: mdl-37904171

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Antígeno Prostático Específico Limite: Humans / Male Idioma: En Revista: BMC Urol Assunto da revista: UROLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Japão

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Antígeno Prostático Específico Limite: Humans / Male Idioma: En Revista: BMC Urol Assunto da revista: UROLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Japão